Dietary Intake and Nutrient Status of Children With ADHD

This study has been completed.
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by:
University of British Columbia
ClinicalTrials.gov Identifier:
NCT00434928
First received: February 13, 2007
Last updated: NA
Last verified: February 2007
History: No changes posted
  Purpose

Assess the dietary intake of children aged 6-12 years by means of a 24-hour recall and 3-day food record and asses the nutrient status of Vitamin B6, serum ferritin, serum zinc and serum copper of the same children by means of standard laboratory assessments.


Condition
Attention Deficit Hyperactivity Disorder

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Official Title: Dietary Intake and Nutrient Status of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Resource links provided by NLM:


Further study details as provided by University of British Columbia:

Estimated Enrollment: 60
Study Start Date: January 2006
Estimated Study Completion Date: January 2007
Detailed Description:
  • To document the use of vitamin and vitamin-mineral supplements
  • To determine the percent consumption of low nutrient density (LND) foods
  • To compare the dietary intake of ADHD children with the established standards of the Dietary Reference Intakes (DRIs)
  • To compare the dietary intake of children with ADHD to the dietary recommendations of Canada’s Food Guide for Healthy Eating
  • To determine whether dietary intake is moderated by drug treatment
  • To assess the pyridoxal-5’-phosphate (PLP), serum ferritin, serum zinc, and serum copper status of ADHD by standard laboratory blood test
  • to measure height and weight in ADHD children
  Eligibility

Ages Eligible for Study:   6 Years to 12 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Primary diagnosis of ADHD
  • Age 6-12 years inclusive

Exclusion Criteria:

  • No use of medication that affects dietary intake (eg. Risperdal)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00434928

Locations
Canada, British Columbia
Provincial ADHD Program, BC Children's Hospital
Vancouver, British Columbia, Canada
Sponsors and Collaborators
University of British Columbia
Eli Lilly and Company
Investigators
Principal Investigator: Margaret D. Weiss, MD University of British Columbia
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00434928     History of Changes
Other Study ID Numbers: H05-70464, W05-0185
Study First Received: February 13, 2007
Last Updated: February 13, 2007
Health Authority: Canada: Health Canada

Keywords provided by University of British Columbia:
observational
dietary intake
nutrient status
serum assessors
Attention-Deficit/Hyperactivity Disorder (ADHD)

Additional relevant MeSH terms:
Attention Deficit Disorder with Hyperactivity
Hyperkinesis
Attention Deficit and Disruptive Behavior Disorders
Mental Disorders Diagnosed in Childhood
Mental Disorders
Dyskinesias
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on April 23, 2014